Our studies (Reference [21] and this study) have revealed a regulatory feedback mechanism that places β-catenin-LC3 II/P62-caspase-8 in a loop of proliferation, autophagy, and apoptosis to be compromised, with implications for drug targeting of these pathways for GBM cells to THD [21]. The gene discussed is CASP8; the disease is glioblastoma.